105
Participants
Start Date
August 2, 2022
Primary Completion Date
May 13, 2025
Study Completion Date
May 13, 2025
NNC6019-0001
Participants will receive i.v infusionof NNC6019-0001.
Placebo (NNC6019-0001)
Participants will receive i.v. infusion of placebo (NNC6019-0001).
II. interni klinika VFN - Kardiologie a angiologie, Prague
Univ of MD Schl of Med, Baltimore
University of Maryland School of Medicine, Baltimore
Centro per lo Studio e la Cura delle Amiloidosi Sistemiche Fondazione IRCCS Policlinico San Matteo, Pavia
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda
Hospital Universitario Puerta de Hierro Majadahonda, Madrid
Centre Hospitalier Universitaire de Toulouse-Hopital Rangueil-1, Toulouse
Centre Hospitalier Universitaire de Toulouse-Hopital Rangueil-1, Toulouse Cedex 9 TSA 50032
Mayo Clinic Jacksonville, Jacksonville
Universitätsklinikum Münster - Klinik für Kardiologie I, Münster
Mayo Clinic Rochester, Rochester
Fondazione CNR-Regione Toscana Gabriele Monasterio, Pisa
NW Univ-Bluhm Cardiovasc Inst, Evanston
UniklinikHeidelberg - Innere Med. III - Kardiologie, Angiologie, Pneumologie, Heidelberg
LMU Klinikum München Klinik und Poliklinik 1, München
Mayo Clinic Arizona, Phoenix
Cedars-Sinai Medical Center_Los Angeles, Beverly Hills
Ap-Hp-Hopital Henri Mondor, Créteil
Stanford Hlth Cre-Boswell Clin, Stanford
Universitatsklinikum Wurzburg AöR, Würzburg
Universitatsklinikum Würzburg - Zentrum für Herzinsuffizienz, Würzburg
Oregon Hlth Sci Univ-Portland, Portland
University of Calgary_Cardiology, Calgary
Ctr for Cardiovascular Innovation, Vancouver
Hospital of the University of Occupational and Environmental Health, Cardiology, Nephrology, Fukuoka
Hiroshima University hospital, Cardiovascular Medicine, Hiroshima
Kumamoto University Hospital, Cardiovascular Medicine, Kumamoto-shi, Kumamoto
Shinshu University Hospital, Department of Neurology, Nagano
Nagasaki University Hospital, Cardiovascular Medicine, Nagasaki
Okayama University Hospital_Cardiovascular Medicine, Okayama-shi, Okayama
UMC Groningen, Groningen
Universitair Medisch Centrum Utrecht, Utrecht
Hospital da Senhora da Oliveira - Guimarães, Guimarães
Unidade Local de Saude do Alto Ave, E.P.E., Guimarães
Lead Sponsor
Novo Nordisk A/S
INDUSTRY